Halipa, Jaharia .
HRN: 18-69-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/09/2025
12/16/2025
IV
500mg
Q8
S/p Cs
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes